Interestingly, UBE2D3 was found upregulated in ATRA-treated NB4 acute promyelocytic leukemia cells, leading to UBE2D3-mediated degradation of cyclin D1 and cell cycle arrest (11). The gene discussed is UBE2D3; the disease is acute promyelocytic leukemia.